Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127212683 | 12721268 | 3 | F | 20160709 | 20160914 | 20160907 | 20160922 | EXP | JP-ASTRAZENECA-2016SE91916 | ASTRAZENECA | 29038.00 | DY | F | Y | 0.00000 | 20160922 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127212683 | 12721268 | 1 | PS | IRESSA | GEFITINIB | 1 | Oral | 1500 | MG | U | 206995 | 250 | MG | TABLET | QD | ||||
| 127212683 | 12721268 | 2 | C | DICLOFENAC SODIUM. | DICLOFENAC SODIUM | 1 | Oral | 0 | 25 | MG | TABLET | TID | |||||||
| 127212683 | 12721268 | 3 | C | FAMOTIDINE OD | FAMOTIDINE | 1 | Oral | 0 | 20 | MG | TABLET | BID | |||||||
| 127212683 | 12721268 | 4 | C | MICARDIS | TELMISARTAN | 1 | Oral | 0 | 20 | MG | TABLET | QD | |||||||
| 127212683 | 12721268 | 5 | C | PROPIVERINE HYDROCHLORIDE | PROPIVERINE HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
| 127212683 | 12721268 | 6 | C | DENOTAS | CALCIUM CARBONATECHOLECALCIFEROLMAGNESIUM CARBONATE | 1 | Oral | EVERY DAY | 0 | TABLET | |||||||||
| 127212683 | 12721268 | 7 | C | RANMARK | DENOSUMAB | 1 | Unknown | DOSE UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127212683 | 12721268 | 1 | Lung adenocarcinoma |
| 127212683 | 12721268 | 2 | Cancer pain |
| 127212683 | 12721268 | 3 | Prophylaxis |
| 127212683 | 12721268 | 4 | Hypertension |
| 127212683 | 12721268 | 5 | Pollakiuria |
| 127212683 | 12721268 | 6 | Metastases to bone |
| 127212683 | 12721268 | 7 | Metastases to bone |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127212683 | 12721268 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127212683 | 12721268 | Hypertension | |
| 127212683 | 12721268 | Lung disorder | |
| 127212683 | 12721268 | Malignant neoplasm progression | |
| 127212683 | 12721268 | Pollakiuria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127212683 | 12721268 | 1 | 20160708 | 20160713 | 0 | |
| 127212683 | 12721268 | 2 | 20160707 | 20160726 | 0 | |
| 127212683 | 12721268 | 3 | 20160707 | 20160726 | 0 | |
| 127212683 | 12721268 | 4 | 20160709 | 20160726 | 0 | |
| 127212683 | 12721268 | 5 | 20160712 | 20160726 | 0 | |
| 127212683 | 12721268 | 6 | 20160707 | 20160726 | 0 |